Viavi Solutions 2027 Q1 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Viavi Solutions reported fiscal Q1 2027 revenue of $469.3 million, up 5.9% sequentially and 56.9% year over year, above its guidance range of $450 to $460 million.
- Operating margin was 29%, up 5 percentage points sequentially and 12.7 percentage points year over year; it included a net benefit of about 110 basis points from approximately $11 million in tariff refunds, offset by the additional 1 week of some variable costs.
- EPS was $0.47, above guidance of $0.40 to $0.42 and up $0.13 sequentially and $0.32 year over year; it included a net benefit of about $0.02 from tariff refunds and the additional 1 week of variable expenses.
- NSC revenue was $376.1 million, up 74.1% year over year, and included $52.7 million from Spirent product lines; NSC gross margin was 66.2% and operating margin was 25.5%, versus 8.2% in the same quarter last year.
- OSP revenue was $93.2 million, up 12.2% year over year; gross margin was 57.1% and operating margin was 43.2%.
- Cash and short-term investments were $535.3 million at quarter-end; operating cash flow was $104.7 million and CapEx was $12 million.
- Viavi purchased about 3,949,000 shares for about $150 million at an average share price of $37.98 during the quarter; about $18 million remained under the current authorization, and the board authorized a new $500 million buyback plan.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good afternoon. My name is Jonathan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Viavi Solutions fiscal first quarter 2027 earnings call. Today's conference is being recorded. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question, please press star one on your telephone keypad to raise your hand. If you wish to remove your question, press star one again. At this time, I would like to turn the call over to Vibhuti Nayar, Head of Investor Relations.
Please go ahead. Thank you, Jonathan.
Good afternoon, everyone. Welcome to Viavi Solutions fiscal first quarter 2027 earnings call. My name is Vibhuti Nayar, Head of Investor Relations for Viavi Solutions. With me on today's call are Oleg Khaykin, our President and CEO, and Ilan Daskal, our CFO. Please note, this call will include forward-looking statements about the company's financial performance, outlook, and longer-term growth strategy. These rest on a number of assumptions, such as sustained capital spending, particularly by data center ecosystem, service providers, and aerospace and defense customers, our ability to maintain or gain market share, and develop and deliver new products on time, adequate component availability, and stable macroeconomic conditions. These assumptions are not exhaustive, and additional assumptions, risks, and uncertainties are discussed in our filings with the SEC.
These statements are subject to risks and uncertainties that could cause actual results to differ materially from our current estimations and expectations. Please review our most recent annual report on Form 10-K, filed with the SEC on August 13, 2026, and our quarterly SEC filings, particularly the risk factors described in those filings, for additional information regarding the assumptions, risks, and uncertainties underlying these forward-looking statements. These forward-looking statements, including the guidance that we provide during this call and our expectations regarding the end markets, revenue growth, and market expansion, are valid only as of today. Viavi undertakes no obligation to update these statements. Please also note that unless we state otherwise, all results discussed on this call, except revenue, are non-GAAP. We reconcile these non-GAAP results to our preliminary GAAP financials and discuss their usefulness and limitations in today's earnings release.
The release, as well as our supplemental earnings slides, which include historical financial tables, are available on Viavi's website at www.investor.viavisolutions.com. Finally, we are recording today's call and will make the recording available on our website by 4:30 P.M. Pacific Time this evening. With that, I would like to turn the call over to Ilan.
Ilan? Thank you, Vibhuti. Good afternoon, everyone.
Now I would like to review the results of the first quarter of fiscal year 2027. Net revenue for the quarter was $469.3 million, which is above the high end of our guidance range of $450 million-$460 million. Revenue was up 5.9% sequentially, and on a year-over-year basis, was up 56.9%. Operating margin for the first fiscal quarter was 29%, above the high end of our guidance range of 26.7%-27.5%. Operating margin expanded 5 percentage points from the prior quarter, and on a year-over-year basis, was 12.7 percentage points higher. Operating margin included a net benefit of about 110 basis points from tariff refund of approximately $11 million, which was offset by the additional one week of some variable costs.
EPS at $0.47 was well above our guidance range of $0.40-$0.42 and was up $0.13 sequentially. On a year-over-year basis, EPS was up $0.32. EPS includes a net benefit of about $0.02 from tariff refunds and from the additional one week of variable expenses. Moving on to our Q1 results by business segment. NSE revenue for the first fiscal quarter came in at $376.1 million, which is above the high end of our guidance range of $360 million-$368 million. Revenue from Spirent product lines was $52.7 million. On a year-over-year basis, NSE revenue was up 74.1% as a result of continued strong demand for our lab and production and field products, driven by the data center, as well as the acquisition of Spirent product lines. We also saw strong demand for our aerospace and defense products.
NSE gross margin for the quarter was 66.2%, which is 310 basis points higher on a year-over-year basis, and was mainly driven by the tariff refunds and product mix. NSE's operating margin for the quarter was 25.5% versus 8.2% during the same quarter last year. NSE operating margin was well above our guidance range of 22.6%-23.6%, mainly as a result of higher fall-through. OSP revenue for the first fiscal quarter came in at $93.2 million, which is also above the high end of our guidance range of $90 million-$92 million. On a year-over-year basis, OSP revenue was up 12.2%, driven by strength in 3D sensing and anti-counterfeiting and other products. OSP gross margin was 57.1%, up 460 basis points on a year-over-year basis, primarily driven by higher volume and favorable product mix.
OSP's operating margin was 43.2%, which is in line with our guidance range of 43%-43.4%. OSP operating margin increased 600 basis points on a year-over-year basis. Moving on to the balance sheet and cash flow. Total cash and short-term investments at the end of Q1 were $535.3 million, compared to $656.7 million in the fourth fiscal quarter of 2026. Cash flow from operating activities for the quarter was $104.7 million versus $31 million in the same period last year, and was driven by higher net income and timing of working capital. CapEx for the quarter was $12 million versus $8.5 million in the same period last year. During the first quarter, we purchased about 3,949,000 shares of our stock for about $150 million at an average share price of $37.98.
We have about $18 million remaining under the current authorized share repurchase program, and our board of directors has authorized a new buyback plan of $500 million. Our capital allocation strategy will continue to focus on organic growth, potential M&A targets, as well as opportunistic share buybacks. The fully diluted share count for the quarter was 266.2 million shares, up from 227.9 million shares in the prior year, and versus 268 million shares in our guidance for the first fiscal quarter. Moving on to our guidance for the second quarter of fiscal year 2027. We expect the second fiscal quarter revenue for Viavi to be up sequentially, driven by continued strength in our key end markets. We expect quarter-over-quarter growth to continue throughout the rest of the fiscal year, driven by tailwinds in our end markets.
For NSE, we expect second fiscal quarter revenue to be up as a result of continued strong demand for lab and production and field products, driven by the data center ecosystem, as well as aerospace and defense customers. For OSP, we expect quarter-over-quarter revenue to be lower, in line with seasonality of lower demand for 3D sensing and anti-counterfeiting and other products. For the second fiscal quarter of 2027, we expect Viavi revenue in the range of $505 million and $515 million. We expect NSE revenue in the second fiscal quarter of 2027 between $426 million and $434 million. OSP revenue is expected to be in the range of $79 million and $81 million. Operating margin for Viavi is expected to be 29.3%, plus or minus 30 basis points. NSE operating margin is expected to be 28.1%, plus or minus 30 basis points.
OSP operating margin is expected to be 35.7%, plus or minus 20 basis points, and EPS is expected to be between $0.50 and $0.52. Our tax expenses for the second quarter are expected to be around $12 million, plus or minus $500,000, as a result of jurisdictional mix. We expect other income and expenses to reflect a net expense of approximately $3.5 million, and the share count is expected to be around 264 million shares. With that, I will turn the call over to Oleg.
Oleg? Thank you, Ilan. The first quarter coming in above the high end of our guidance.
Our fiscal 2027 is off to a good start. The year-on-year performance was driven by strong growth in many of our end markets. NSE revenue in fiscal Q1 grew approximately 74% year-over-year, primarily driven by continued strong demand from the data center and aerospace and defense customers. More specifically, the data center segment, which includes high-performance semis, optical modules, NEMs, and hyperscalers, drove strong demand for lab and production and field instruments in support of the scale-up, scale-out, and scale-across applications. In addition to the traditional lab and production end markets, we also expanded our TAM to include the semiconductor packaging and test. With the adoption of NPO and CPO technologies, we expect the semiconductor packaging and test segment to become a major new growth area for Viavi.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
9 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
